Morbidity and Mortality of Diabetic Ketoacidosis With and Without Insulin Pump Care
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Diabetic ketoacidosis (DKA) is one of the most common, costly, and dangerous acute complications in people with type 1 diabetes (T1D). Although DKA has been reported to occur with less frequency than severe hypoglycemia, it is associated with a higher mortality rate and is the leading cause of diabetes-related deaths in children and adolescents. The most common risk factor for DKA is lack of adherence to insulin treatment. Other factors include underinsurance, psychiatric disorders, occlusion of insulin pump infusion sets, and illness. It has been suggested that use of continuous subcutaneous insulin infusion therapy may increase the risk for DKA, although clinical trials have not supported this claim. Expert care within a T1D specialty clinic may help reduce the risk of DKA mortality. Further advances are needed in developing new technologies and methods to improve glycemic control in intensively treated patients without increasing the risk of acute complications. The purpose of this review is to discuss DKA morbidity and mortality in youth with T1D, particularly in relation to insulin pump use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Continuous glucose monitoring and intensive treatment of type 1 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805017 · Cited by 1,559
Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes
Bergenstal, R. M., Tamborlane, W. V., Ahmann, A., Buse, J. B., Dailey, G., Davis, S. N., Joyce, C., Peoples, T., Perkins, B. A., Welsh, J. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002853 · Cited by 894
(1995) · Diabetes Care · doi:10.2337/diacare.18.11.1415 · Cited by 305
Patterson, C. C., Dahlquist, G., Harjutsalo, V., Joner, G., Feltbower, R. G., Svensson, J., Schober, E., Gyürüs, E., Castell, C., Urbonaité, B., et al. (2007) · Diabetologia · doi:10.1007/s00125-007-0824-8 · Cited by 213
Recurrent Diabetic Ketoacidosis in Inner-City Minority Patients
Randall, L., Begovic, J., Hudson, M., Smiley, D., Peng, L., Pitre, N., Umpierrez, D., & Umpierrez, G. (2011) · Diabetes Care · doi:10.2337/dc11-0701 · Cited by 207
Insulin Pump Therapy With Automated Insulin Suspension in Response to Hypoglycemia
Choudhary, P., Shin, J., Wang, Y., Evans, M. L., Hammond, P. J., Kerr, D., Shaw, J. A. M., Pickup, J. C., & Amiel, S. A. (2011) · Diabetes Care · doi:10.2337/dc10-2411 · Cited by 175
Prevention of Nocturnal Hypoglycemia Using Predictive Alarm Algorithms and Insulin Pump Suspension
Buckingham, B., Chase, H. P., Dassau, E., Cobry, E., Clinton, P., Gage, V., Caswell, K., Wilkinson, J., Cameron, F., Lee, H., et al. (2010) · Diabetes Care · doi:10.2337/dc09-2303 · Cited by 169 · cited 5×
“Further research is needed to determine the best resources and environments to prevent DKA-related morbidity and mortality in patients with known T1D.”
InfluentialSelf-citationHanas, R., Lindgren, F., & Lindblad, B. (2009) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2008.00441.x · Cited by 129
Berghaeuser, M., Kapellen, T., Heidtmann, B., Haberland, H., Klinkert, C., Holl, R., & for the DPV-Science-Initiative and the German working group for insulin pump treatment in paediatric patients (2008) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2008.00416.x · Cited by 58 · cited 1×
“18 The success of the pre-school age group may be attributed to the fact that the parents are very involved in the diabetes management in this young population.”
Cited by
Effects of sotagliflozin added to insulin in patients with type 1 diabetes
Garg, S. K., Henry, R. R., Banks, P., Buse, J. B., Davies, M. J., Fulcher, G. R., Pozzilli, P., Gesty-Palmer, D., Lapuerta, P., Simó, R., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1708337 · Cited by 417
Ehrmann, D., Kulzer, B., Roos, T., Haak, T., Al-Khatib, M., & Hermanns, N. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30042-5 · Cited by 141
Garg, S. K., Peters, A. L., Buse, J. B., & Danne, T. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0246 · Cited by 108
“In the emergency department, the same protocol involving carbohydrates, fluids, and insulin should be used to treat DKA.”
InfluentialFlores, M., Amir, M., Ahmed, R., Alashi, S., Li, M., Wang, X., Lansang, M. C., & Al-Jaghbeer, M. J. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001329 · Cited by 43
Real-Time Detection of Infusion Site Failures in a Closed-Loop Artificial Pancreas
Howsmon, D. P., Baysal, N., Buckingham, B. A., Forlenza, G. P., Ly, T. T., Maahs, D. M., Marcal, T., Towers, L., Mauritzen, E., Deshpande, S., et al. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818755173 · Cited by 32
“Inability to recognize SFs can lead to diabetic ketoacidosis (DKA), a high-cost acute complication that may be fatal.(17,18) Although the incidence of DKA is not increased by CSII pump use over multiple daily injections,(17,18) problems with the pump (eg, SFs) are the largest contributor to development of DKA(19,20) a…”
Background
Metadata
- Authors
- Realsen, J., Goettle, H., & Chase, H. P.
- Venue
- Diabetes Technology & Therapeutics
- Publisher
- SAGE Publications
- Published
- 2012-12
- Volume
- 14
- Issue
- 12
- Pages
- 1149-1154
- ISSN
- 1520-9156 (ISSN-L)
- 1557-8593
- OpenAlex
- W2089682905
- Cited by
- 73
- References
- 9
- FWCI
- 1.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Morbidity and Mortality of Diabetic Ketoacidosis With and Without Insulin Pump Care. https://app.cochat.ai/papers/10.1089/dia.2012.0161
- The paper
- Realsen, J., Goettle, H., & Chase, H. P. (2012). Morbidity and Mortality of Diabetic Ketoacidosis With and Without Insulin Pump Care. Diabetes Technology & Therapeutics. https://doi.org/10.1089/dia.2012.0161
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.